"Ospedale Generale Regionale "F. Miulli""

During the past decade, Ospedale Generale Regionale "F. Miulli" conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 9 clinical trials were completed, i.e. on average, 36% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Generale Regionale "F. Miulli"" #1 sponsor was "Biosense Webster, Inc." with 10 trials, followed by "Miulli General Hospital" with 5 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Catholic University of the Sacred Heart" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Generale Regionale "F. Miulli"" #1 collaborator was "Miulli General Hospital" with 2 trials as a collaborator, "Hippocrates Research" with 1 trials as a collaborator and "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Generale Regionale "F. Miulli"" are "Atrial Fibrillation" (10 trials), "Parkinson's Disease" (3 trials), "Heart Failure" (2 trials), "Hypertension, Renal" (2 trials) and "Paroxysmal Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Ospedale Generale Regionale "F. Miulli"" in a lesser frequency.

Most popular intervention types in "Ospedale Generale Regionale "F. Miulli"" are "Device" (15 trials), "Drug" (13 trials), "Other" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Edoxaban" (2 trials), "Androgen Deprivation Therapy (ADT)" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Generale Regionale "F. Miulli"" are 29 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Generale Regionale "F. Miulli"". 1 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Ospedale Generale Regionale "F. Miulli", undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Generale Regionale "F. Miulli", 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".

Ospedale Generale Regionale "F. Miulli" has several departments that took part in Clinical trials: "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica" - 4 trials, "Ospedale Miulli, U.O.C. Cardiologia - Utic" - 2 trials